Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment

E-ISSN： 1873-5576|7|6|566-581

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.6, 2007-01, pp. : 566-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting angiogenesis for the treatment of prostate cancer

By Antonarakis Emmanuel S Carducci Michael A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Targeting integrins for the control of tumour angiogenesis

By Akalu Abebe Cretu Alexandra Brooks Peter C

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1475-1486

Informa Healthcare

Access to resources Recommend Favorite

DNA enzymes may inhibit tumour angiogenesis and growth

Inpharma, Vol. 1, Iss. 1446, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

By Fan T.-P.D. Jaggar R. Bicknell R.

Trends in Pharmacological Sciences, Vol. 16, Iss. 2, 1995-02 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I. Moase Elaine H. Allen Theresa M.

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite